Prognosis of MRT in the frame of RTPS appears to be inferior to sporadic tumors [16, 44], and this seems to be true for SMARCB1 as well as for SMARCA4 associated RTPS. The gene discussed is SMARCA4; the disease is familial rhabdoid tumor.